Capital Markets

Stockholm – September 18, 2026 -- SciBase Holding AB has pushed back the first day of trading in subscription rights and paid subscribed shares (BTA) tied to its ongoing rights issue by one day, moving the start date from September 18, 2026 to September 18, 2026 on Nasdaq First North Growth Market.

The subscription period itself remains unchanged, running from September 15 through September 18, 2026.

Timetable shift leaves subscription window intact

The Swedish medtech company confirmed the updated timetable applies only to the trading commencement of subscription rights and BTAs, not to the underlying subscription mechanics of the capital raise.

Michael Colérus, Chief Financial Officer of SciBase, is the designated contact for investor inquiries related to the adjustment.

Parsippany-Troy Hills, N.J. – September 18, 2026 -- PBF Energy Inc.'s subsidiary PBF Holding Company LLC has priced $500 million in 0% exchangeable notes due 2032, with net proceeds earmarked largely to retire its existing 7.875% Senior Unsecured Notes due 2030.

PBF Holding sets zero-coupon terms with 37.5% exchange premium

The notes, co-issued with PBF Finance Corporation, carry no regular interest and will not accrete in principal. The initial exchange price is approximately $96.80 per share, a 37.5% premium over PBF Energy's $70.40 closing share price on the New York Stock Exchange on September 18, 2026. Initial purchasers hold an option to buy up to $50 million in additional notes within 13 days of issuance.

Hellerup – September 18, 2026 -- TORM plc has launched a secondary public offering of 9,000,000 Class A common shares on behalf of OCM Njord Holdings S.à r.l., a vehicle indirectly owned by funds managed by Oaktree Capital Management, L.P.

Oaktree-linked seller holds roughly 20% of TORM's Class A shares before the sale

OCM Njord Holdings currently owns approximately 20% of TORM's Class A common shares. The selling shareholder is expected to grant the underwriter a 30-day option to purchase up to an additional 1,350,000 shares, which could lift the total offering size to 10,350,000 shares.

TORM will not receive proceeds as the sale is entirely secondary

The Nasdaq-listed product tanker operator (TRMD, TRMD A) is not selling any shares itself and will not collect proceeds from the transaction. J.P. Morgan Securities LLC is acting as sole underwriter, offering the shares to the public at a fixed price that may be adjusted without notice.

Murfreesboro – September 18, 2026 -- National Health Investors (NYSE: NHI) has amassed approximately $608.7 million in combined investment opportunities as management prepares to meet investors at the BofA Securities 2026 Global Real Estate Conference on September 15.

NHI holds $272.0 million under signed letters of intent for new acquisitions

The senior housing REIT disclosed that it currently has roughly $272.0 million of investment opportunities under signed Letters of Intent, alongside an additional $51.7 million tied to real estate purchase options.

Company plans to deploy 1031 exchange proceeds from NHC portfolio sale

NHI expects to use proceeds from a Section 1031 exchange transaction initiated by its NHC portfolio sale to fund a significant portion of these committed opportunities. Completing the exchanges would defer recognition of a substantial share of the taxable gain generated by the NHC sale.

Jersey City, N.J. – September 18, 2026 -- Tenon Medical, Inc. (NASDAQ: TNON) has closed a warrant inducement agreement generating $2,872,338.58 in gross proceeds from an institutional investor exercising 572,179 outstanding warrants in full.

Institutional investor exercises warrants for immediate cash proceeds

The exercising holder converted 572,179 existing warrants into common stock, delivering gross cash proceeds of $2,872,338.58 to Tenon before deducting advisor fees and other expenses.

Company issues new warrants covering 858,269 shares at $5.02 exercise price

In exchange for the immediate exercise, the investor received new unregistered warrants to purchase up to 858,269 shares of common stock, equal to 150% of the shares issued in the original exercise. The new warrants carry a $5.02 per-share exercise price, are immediately exercisable upon issuance, and expire five years from that date.

Langhorne, Pa. – September 18, 2026 -- TEN Holdings, Inc. (Nasdaq: XHLD) will exhibit at booth #505 during the 2026 GCFF Annual Wealth Conference in Vancouver on September 19, gaining direct access to more than 400 investors and 25-plus public and private companies attending the one-day event at the Executive Hotel Vancouver Airport in Richmond, British Columbia.

Chairman Virgilio Torres to deliver 20-minute investor presentation

Torres, Chairman and CEO of TEN Holdings, is scheduled to present live from 11:30 a.m. to 11:50 a.m. PT, addressing the company's platform roadmap and growth strategy to an audience spanning gold, silver, critical minerals, energy infrastructure, artificial intelligence, capital markets, ETFs and private equity investors.

The conference is hosted by NAI500 in partnership with the Global Chinese Financial Forum, positioning it as one of Western Canada's largest investment-focused gatherings.

Vancouver – September 17, 2026 -- First Mining Gold Corp. (TSX: FF; OTCQX: FFMGF; FRANKFURT: FMG) will join the MVIS Global Junior Gold Miners Index (MVGDXJ), the benchmark tracked by the VanEck Junior Gold Miners ETF (GDXJ), effective at the close of trading on September 18, 2026.

Index inclusion follows semi-annual GDXJ rebalancing

The addition comes through the MVGDXJ's scheduled semi-annual review, placing First Mining among the most liquid small-cap gold and silver mining, development and exploration companies tracked globally. The MVGDXJ is a modified market-cap-weighted index restricted to companies generating at least 50% of revenue from gold or silver, or holding at least 50% of mineral resources in those metals.

Beijing -- Jianpu Technology Inc. (OTCQB: AIJTY) confirmed that FINRA has fixed September 17, 2026 as the ex-dividend date for the special cash dividend the Chinese fintech platform announced on September 17, 2026.

Dividend payout of $0.499 per ADS exceeds a quarter of share price, forcing regulatory intervention

The special cash dividend of US$0.02495 per ordinary share, equivalent to US$0.499 per American depositary share, surpasses 25% of Jianpu's ADS trading price. Under FINRA rules, this threshold requires the ex-dividend date to fall on the first business day after the payment date rather than before it, pushing the ex-dividend date to September 17, 2026, one day after the scheduled September 17, 2026 payout.

Stockholm – September 17, 2026 -- Telefonaktiebolaget LM Ericsson repurchased Class B shares on Nasdaq Stockholm between September 7 and September 17, 2026, pushing its total treasury stock holding to 107,518,663 Class B shares.

Ericsson executes buyback under a SEK 15 billion program launched in April 2026

The repurchases form part of a share buyback program of up to SEK 15,000,000,000 that Ericsson announced on September 17, 2026. The program runs from September 17, 2026, through September 17, 2026, at the latest.

Goldman Sachs Bank Europe executed all trades on Nasdaq Stockholm

Goldman Sachs Bank Europe SE carried out all acquisitions on behalf of Ericsson during the reporting period, in compliance with the EU Market Abuse Regulation (No 596/2014) and its Safe Harbour Regulation supplement of March 2016.

Dublin – September 17, 2026 -- Davion Healthcare Plc has secured admission of a £30 million senior secured bond to trading on the Vienna MTF, operated by Wiener Börse AG, giving the Irish healthcare group a dedicated capital pool to fund acquisitions.

Bond carries 10.5% fixed coupon over five-year term

The bond, issued through financing subsidiary Davion Healthcare Finance Ltd, commenced in August 2026 and carries a fixed annual coupon of 10.5%. It trades under ISIN GB00BTH2SB89, with a denomination of £100,000 per unit.

Proceeds target acquisitions across five healthcare segments

Davion plans to deploy the capital toward acquiring established, cash-generative businesses in medical devices, diagnostics, medical distribution, healthcare technology and healthcare services. Proceeds are released on an acquisition-by-acquisition basis through Davion Healthcare Finance Ltd, with security granted over each acquired asset.